Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study

Diabetes Care

Volumn 39, Issue 9, 2016, Pages 1535-1542

  Vehik, Kendra ^a   Lynch, Kristian F ^a   Schatz, Desmond A ^b   Akolkar, Beena ^c   Hagopian, William ^d   Rewers, Marian ^e   She, Jin Xiong ^f   Simell, Olli ^g   Toppari, Jorma ^g   Ziegle, Anette G ^h   Lernmark, Ake ⁱ   Bonifacio, Ezio ^j,k   Krischer, Jeffrey P ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF COLORADO DENVER   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ LUND UNIVERSITY   (Sweden)

^j CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^k GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; INSULINOMA ANTIGEN 2 ANTIBODY; UNCLASSIFIED DRUG; GLUTAMATE DECARBOXYLASE; INSULIN; PTPRN PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEX DIFFERENCE; SURVIVAL TIME; BLOOD; FEMALE; GENOTYPE; IMMUNOLOGY; MALE; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR;

AUTOANTIBODIES; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; INSULIN ANTIBODIES; INSULIN-SECRETING CELLS; MALE; PROSPECTIVE STUDIES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; RISK ASSESSMENT; RISK FACTORS; SEROCONVERSION;

EID: 84986211384     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0181     Document Type: Article

References (25)

1. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 1997; 46:1701-1710
2. Bonifacio E, Bingley PJ. Islet autoantibodies and their use in predicting insulin-dependent diabetes. Acta Diabetol 1997;34:185-193
3. Orban T, Sosenko JM, Cuthbertson D, et al.; Diabetes Prevention Trial-Type 1 Study Group. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial- Type 1. Diabetes Care 2009;32:2269-2274
4. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309:2473-2479
5. Kimpimäki T, Kulmala P, Savola K, et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited fromthe general population. J Clin Endocrinol Metab 2002;87:4572-4579
6. Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF. Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulindependent diabetes. Lancet 1984;1:764-766
7. Barker JM, Barriga KJ, Yu L, et al.; Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004;89:3896-3902
8. Hagopian WA, Erlich H, Lernmark A, et al.; TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): Genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011;12:733-743
9. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann N Y Acad Sci 2008;1150:1-13
10. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: Study design. Pediatr Diabetes 2007;8: 286-298
11. Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95:3360-3367
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl. 1):S81-S90
13. Krischer JP, Cuthbertson DD, Yu L, et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 2003;88:103-108
14. Krischer JP, Lynch KF, Schatz DA, et al.; TEDDY Study Group. The 6 year incidence of diabetes- associated autoantibodies in genetically at-risk children: The TEDDY study. Diabetologia 2015;58:980-987
15. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48: 460-468
16. Achenbach P, Warncke K, Reiter J, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004;53:384-392
17. Bonifacio E, Bingley PJ, Shattock M, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-149
18. Vehik K, Haller MJ, Beam CA, et al.; DPT-1 Study Group. Islet autoantibody seroconversion in the DPT-1 study: Justification for repeat screening throughout childhood. Diabetes Care 2011;34:358-362
19. Vehik K, Beam CA, Mahon JL, et al.; TrialNet Natural History Study Group. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care 2011;34:1897-1901
20. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes 2005;54(Suppl. 2):S25-S31
21. Colman PG, Steele C, Couper JJ, et al. Islet autoimmunity in infants with a type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 2000;43: 203-209
22. Naserke HE, Bonifacio E, Ziegler AG. Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 2001;86:4826-4833
23. Steck AK, Vehik K, Bonifacio E, et al.; TEDDY Study Group. Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 2015;38:808-813
24. Bollyky JB, Xu P, Butte AJ,Wilson DM, Beam CA, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Heterogeneity in recent-onset type 1 diabetes-a clinical trial perspective. Diabetes Metab Res Rev 2015;31:588-594
25. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG. Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004;140: 882-886